NHT
ABBV icon

New Hampshire Trust’s AbbVie ABBV Stock Holding History

New Hampshire Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Sell
33,795
-238
-0.7% -$51.2K 1.6% 14
2026
Q1 		$7.4M Sell
34,033
-195
-0.6% -$43.3K 1.49% 17
2025
Q4 		$7.82M Sell
34,228
-2,441
-7% -$556K 1.52% 13
2025
Q3 		$8.49M Buy
36,669
+658
+2% +$134K 1.64% 14
2025
Q2 		$6.68M Buy
36,011
+763
+2% +$142K 1.4% 14
2025
Q1 		$7.39M Sell
35,248
-966
-3% -$188K 1.69% 12
2024
Q4 		$6.44M Buy
36,214
+99
+0.3% +$18.2K 1.36% 14
2024
Q3 		$7.13M Sell
36,115
-200
-0.6% -$37.3K 1.53% 13
2024
Q2 		$6.23M Sell
36,315
-42
-0.1% -$6.96K 1.42% 14
2024
Q1 		$6.62M Buy
36,357
+1,092
+3% +$188K 1.55% 12
2023
Q4 		$5.47M Sell
35,265
-945
-3% -$138K 1.31% 17
2023
Q3 		$5.4M Sell
36,210
-1,079
-3% -$158K 1.47% 15
2023
Q2 		$5.02M Buy
37,289
+143
+0.4% +$21K 1.31% 18
2023
Q1 		$5.92M Sell
37,146
-1,382
-4% -$211K 1.59% 11
2022
Q4 		$6.23M Buy
+38,528
New +$5.91M 1.65% 10

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

New Hampshire Trust's ABBV Position: Q2 2026 in Review

New Hampshire Trust reduced its AbbVie (ABBV) stake by 0.7% in Q2 2026, selling an estimated $51.2K and leaving 33,795 shares worth $8.5M. The position accounts for 1.6% of the portfolio, ranked #14.

New Hampshire Trust first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • New Hampshire Trust held 33,795 shares of AbbVie worth $8.5M as of Q2 2026.
  • New Hampshire Trust sold 238 AbbVie shares in Q2 2026, an estimated $51.2K.
  • AbbVie made up 1.6% of New Hampshire Trust's portfolio in Q2 2026, its #14 holding.
  • New Hampshire Trust first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.